Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XC8 for Dry Cough in Acute Respiratory Viral Infection
NCT05273619Phase 3Completed
- Sponsor
- Valenta Pharm
- Start
- May 2022
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of histamine glutarimide in acute respiratory viral infection (ARVI), acute bronchitis, sponsored by Valenta Pharm. Started May 2022; status: completed.
02
Drugs
histamine glutarimide
03
Conditions
acute respiratory viral infection (ARVI)acute bronchitis
Beyond the preview
Go deeper on NCT05273619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05273619.